Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) is a publicly traded Healthcare sector company. As of October 26, 2026, CANF trades at $1.75 with a market cap of $3.81M and a P/E ratio of 0.00. CANF moved +0.00% today. Year to date, CANF is -55.50%; over the trailing twelve months it is -81.56%. Its 52-week range spans $1.75 to $46.60. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces CANF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CANF combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.75 |
| Market Cap | $3.81M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.60 |
| 52-Week Low | $1.75 |
| Volume | 693.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover CANF: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.